Phillip Frost - Jul 18, 2023 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role: Director, 10%+ Owner
Signature: /s/ Phillip Frost, MD, ET AL__
Stock symbol: COCP
Transactions as of: Jul 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 7/20/2023, 04:05 PM
Previous filing: May 19, 2023
Next filing: Aug 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	COCP	Stock Options (Right to Buy)	Award	$0	+19.3K		$0.00	19.3K	Jul 18, 2023	Common Stock	19.3K	$2.67	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.

Content

The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.